CHAPTER 12 REFERENCES

Abbas DF, Blum J, Ngoc NT, et al. Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial. Obstet Gynecol. 2016 Nov;128(5):1077-1083. https://bit.ly/3EU171w   

ACOG Practice Bulletin 135: Second Trimester Abortion, 121(6):p 1394-1406, June 2013; Reaffirmed 2017, 2023. https://bit.ly/42sTnuJ

ACOG Committee Opinion No 700: Methods for Estimating the Due Date. Obstet Gynecol. 2017 May;129(5):e150-e154. https://bit.ly/3XtNIDG

Adu-Bredu TK, Rijken MJ, Nieto-Calvache AJ, et al. A simple guide to ultrasound screening for placenta accreta spectrum for improving detection and optimizing management in resource limited settings. Int J Gynaecol Obstet. 2023 Mar;160(3):732-741. http://bit.ly/3UdCL6m

AJOG: Premkumar A, Huysman B, et al. Placenta accreta spectrum in the second trimester: a clinical conundrum in procedural abortion care. Am J Obstet Gynecol. 2025 Jan;232(1):92-101. https://bit.ly/3FRKUtT

Akhtar KS, Chen A, Standfield NJ, et al The role of simulation in developing surgical skills. Curr Rev Musculoskelet Med. 2014 Jun;7(2):155-60. bit.ly/4jn5rF7

Ali MK, Botros HA, Mostafa SA. Foley’s catheter balloon for induction of mid-trimester missed abortion with or without traction applied: a randomized controlled trial. J Matern Fetal Neonatal Med. 2020 Jan;33(2):198-205. https://bit.ly/4hLfmmI

ANSiRH. Global Turnaway Study. https://bit.ly/41EsXqd

Baldwin MK, Chor J, Chen BA, et al. Comparison of 3 dilation and evacuation technical skills models. J Grad Med Educ. 2013 Dec;5(4):662-4. http://bit.ly/3JVr3bG

Bearak JM, Jones RK. Cross-state travel for abortion care. Lancet. 10; June 2022;100230. http://bit.ly/4398klN

Bettelheim A, Parwani S. Charted: Abortion travel distances, two years after Dobbs. Axios June 2024. https://bit.ly/43oqz9x

Blum J, Raghavan S, Dabash R, et al. Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam. Int J Gynaecol Obstet. 2012 Aug;118(2):166-71. https://bit.ly/3enUIsU

Bowyer MW, Andreatta PB, Armstrong JH, Remick KN, Elster EA. A Novel Paradigm for Surgical Skills Training and Assessment of Competency. JAMA Surg. 2021;156(12):1103–1109. https://bit.ly/3S32Ip5

Coast E, Lattof SR, Meulen Rodgers YV, et al. The microeconomics of abortion: A scoping review and analysis of the economic consequences for abortion care-seekers. PLoS One. 2021 June 9;16(6):e0252005. http://bit.ly/3lwJ2ND

Dabash R, Chelli H, Hajri S, et al. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy. Int J Gynaecol Obstet. 2015 Jul;130(1):40-4. https://bit.ly/4ifimsk

Darney PD, Sweet RL. Routine intraoperative ultrasonography for second trimester abortion reduces incidence of uterine perforation. J Ultrasound Med. 1989 Feb;8(2):71-5. https://bit.ly/3U0Ypus

Dean G, Colarossi L, Porsch L, et al. Misoprostol dose and timing before surgical abortion at 13 to 16 weeks’ gestation: a randomized trial. Contraception 2017 Oct; 96(4): 264. https://bit.ly/3j6hsle

Debbink MLP, Hassinger JA, Martin LA, et al. Experiences With the Providers Share Workshop Method: Abortion Worker Support and Research in Tandem. Qual Health Res. 2016 Nov;26(13):1823-1837 https://bit.ly/2zcs7rx

Dickinson JE, Doherty DA. Optimization of third-stage management after second-trimester medical pregnancy termination. Am J Obstet Gynecol. 2009 Sep;201(3):303.e1-7. https://bit.ly/4lfcMIW

Foster DG, Gould H, Biggs MA. Timing of pregnancy discovery among women seeking abortion. Contraception. 2021 Dec;104(6):642-647. https://bit.ly/41YEroA

Foster DG. New Abortion Bans Will Increase Existing Health and Economic Disparities. Am J Public Health. 2022 Sep;112(9):1276-1277. http://bit.ly/3JXzqou

Gemzell-Danielsson K, Lalitkumar S. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters. 2008 May;16(31 Suppl):162-72. https://bit.ly/3mZYdj4

Goodman S, McNeil S, Shih G. Simulation for Managing Hemorrhage as a Complication of Uterine Aspiration. MedEdPortal 2015. https://bit.ly/3gjTS11

Grimes DA, Schulz KF, Cates W Jr. Prevention of Uterine Perforation During Curettage Abortion. JAMA, 1984; 251:2108-2111. http://bit.ly/3MkOHRY

Grimes D, Schulz KF, Cates W, et al. Mid-Trimester Abortion by Dilation and Evacuation — A Safe and Practical Alternative. http://bit.ly/3zFhf0Y

Grossman D, Blanchard K, Blumenthal P. Complications after second trimester surgical and medical abortion. Reprod Health Matters. 2008 May;16(31 Suppl):173-82. https://bit.ly/4j6GopJ

Guttmacher. Bans on Specific Abortion Methods Used After the First Trimester. 2023. https://bit.ly/42986eX

Harris LH, Debbink M, Martin L, et al. Dynamics of stigma in abortion work: findings from a pilot study of the Providers Share Workshop. Soc Sci Med. 2011 Oct;73(7):1062-70. https://bit.ly/442V42A

Hashim H, Nawawi O. Uterine arteriovenous malformation. Malays J Med Sci. 2013 Mar;20(2):76-80. https://bit.ly/42iynbI

Henkel A, Blumenthal PD. Second-trimester abortion care for those with complex medical conditions. Curr Opin Obstet Gynecol. 2022 Dec 1;34(6):359-366. http://bit.ly/3yYo5OD

Henkel A, Johnson SA, Reeves MF, et al. Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss: A Randomized Controlled Trial. Obstet Gynecol. 2023 Jun 1;141(6):1115-1123. https://bit.ly/3FRsqty

Ipas. Second-Trimester abortion: A Toolkit for Service Delivery. https://bit.ly/3L11g2y

Ibis Later Abortion Initiative. What is pregnancy tissue viewing and why is it client-centered care? Jan 2021.

Jagsi R, Lehmann LS. The ethics of medical education. BMJ. 2004 Aug 7;329(7461):332-4.https://bit.ly/4kk4mhR

Jauniaux E, Grønbeck L, Bunce C, et alL. Epidemiology of placenta previa accreta: a systematic review and meta-analysis. BMJ Open. 2019 Nov 12;9(11):e031193. https://bit.ly/4j5n5gH

Jerman J, Frohwirth L, Kavanaugh ML, et al. Barriers to Abortion Care and Their Consequences For Patients Traveling for Services: Qualitative Findings from Two States. Perspect Sex Reprod Health. 2017 Jun;49(2):95-102. http://bit.ly/3ZzYIxp

Jerman J, Jones RK, Onda T. Characteristics of U.S. abortion patients in 2014 and changes since 2008. New York, NY: Guttmacher Institute; 2016. http://bit.ly/3Mn1MKn

Jones R, Nash E, Cross L, et al. Medication Abortion Now Accounts for More Than Half of All US Abortions. Policy Analysis. New York, NY: Guttmacher Institute; 24 Feb 2022. http://bit.ly/3MieI4c

Jones R, Finer LB. Who has second-trimester abortions in the United States? Contraception 2012;85:544-51. https://bit.ly/41zdNRH

Kapp N, Lohr PA. Modern methods to induce abortion: Safety, efficacy and choice. Best Pract Res Clin Obstet Gynaecol. 2020 Feb;63:37-44. https://bit.ly/3n8ZcNM

Keder LM. Best practices in surgical abortion. Am J Obstet Gynecol. 2003 Aug;189(2):418-22. https://bit.ly/422pRfV

KFF; Gomez I, Saganikoff A. Abortions Later in Pregnancy in a Post-Dobbs Era. 2024. https://bit.ly/4hHaiQw

Kimport K. Abortion after Dobbs: Defendants, denials, and delays. Sci Adv. 2022 Sep 9;8(36):eade5327. http://bit.ly/3MfhsQ1

Kortsmit K, Mandel MG, Reeves JA, et al. Abortion Surveillance – United States, 2019. MMWR Surveill Summ. 2021 Nov 26;70(9):1-29. https://bit.ly/3lQUFz4

Kulier R, Kapp N, Gülmezoglu AM, et al. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD002855. https://bit.ly/2X2GR5a

Lerma K, Blumenthal PD. Current and potential methods for second trimester abortion. Best Pract Res Clin Obstet Gynaecol. 2020 Feb;63:24-36. https://bit.ly/4iEwfB5

Lohr PA. Dilation and Evacuation Animation. Innovating Education in Reproductive Health. 2022. http://bit.ly/42A1GVi

Matsuzaki S, Mandelbaum RS, Sangara RN, et al. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States. Am J Obstet Gynecol. 2021 Nov;225(5):534.e1-534.e38. https://bit.ly/41NW1wJ

McDonald J, Yanow S, Young Y. Pushing the Limits in Rural Areas: Increasing Access to Later Abortion in Maine. Ibis. Presented at NAF Feb 2018.

Moseson H, Jayaweera R, Egwuatu I, et al. Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls. Lancet Glob Health. 2022 Jan;10(1):e105-e113. https://bit.ly/3tiijF8

NAF (National Abortion Federation). Clinical Policy Guidelines for Abortion Care. 2024. https://bit.ly/40Rejvh

NASEM Report. National Academies of Sciences, Engineering, and Medicine. 2018. The Safety and Quality of Abortion Care in the United States. Washington, DC: The National Academies Press. https://bit.ly/353HYnR

Newmann SJ, Dalve-Endres A, Diedrich JT, et al. Cervical preparation for second trimester dilation and evacuation. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007310. http://bit.ly/3zyFT30

Nucatola D, Roth N, Saulsberry V, et al. Serious adverse events associated with the use of misoprostol alone for cervical preparation prior to early second trimester surgical abortion (12-16 weeks). Contraception. 2008 Sep;78(3):245-8. http://bit.ly/3ZsuV9K

Paul M, Lichtenberg ES, Borgatta L, et al, Creinin MD. Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care. Wiley-Blackwell: 2009. https://bit.ly/4hCdzAy

Payne C. Low-Tech D&E Training Model Instructional Video. Innovating Education in Reproductive Health. 2016. https://bit.ly/3ngcBmU

Peterson WF, Berry FN, Grace MR, et al. Second-trimester abortion by dilation and evacuation: an analysis of 11,747 cases. Obstet Gynecol. 1983 Aug;62(2):185-90. https://bit.ly/3Apct7Y

Philips J, Gurganus M, DeShields S, et al. Prevalence of sonographic markers of placenta accreta spectrum in low-risk pregnancies. Am J Perinatol. 2019; 36: 733- 780. https://bit.ly/43XrI5H

Premkumar A, Huysman B, Cheng C, et al. Placenta accreta spectrum in the second trimester: a clinical conundrum in procedural abortion care. Am J Obstet Gynecol. 2025 Jan;232(1):92-101. https://bit.ly/3FRKUtT

Rader B, Upadhyay UD, Sehgal NKR, et al. Estimated Travel Time and Spatial Access to Abortion Facilities in the US Before and After the Dobbs v Jackson Women’s Health Decision. JAMA. 2022 Nov 22;328(20):2041-2047. https://bit.ly/4j56bP8

Ralph JA, Shulman LP. Adjunctive Agents for Cervical Preparation in Second Trimester Surgical Abortion. Adv Ther. 2019 Jun;36(6):1246-1251. http://bit.ly/3Gn7Ui5

Ralph LJ, Schwarz EB, Grossman D, et al. Self-reported Physical Health of Women Who Did and Did Not Terminate Pregnancy After Seeking Abortion Services: A Cohort Study. Ann Intern Med. 2019 Aug 20;171(4):238-247. http://bit.ly/3Z2KAfW

Raymond EG, Weaver MA, Shochet T. Effectiveness and safety of misoprostol-only for first-trimester medication abortion: An updated systematic review and meta-analysis. Contraception. 2023 Nov;127:110132. https://bit.ly/4bwFPD7

Schulz KF, Grimes DA, Cates W Jr. Measures to Prevent Cervical Injury During Suction Curettage abortion. Lancet 1983; 1:1182-1185. https://bit.ly/416zo3w

Schwartz LN, Pelletier A, Goldberg AB, et al. Second-Trimester Dilation and Evacuation: A Simulation-Based Team Training Curriculum. MedEdPORTAL. 2023 Aug 15;19:11336.https://bit.ly/4kfH5xz

SFP: Cheng T, Kumar N, Laursen L, et al. on behalf of the Clinical Affairs Committee. SFP clinical recommendation: Prevention of infection after abortion and pregnancy loss. Contraception. 2025 Mar 26:110895. bit.ly/4lT0DcI

SFP: Fox MC, Krajewski CM. Cervical preparation for second-trimester surgical abortion prior to 20 weeks’ gestation. Contraception, 2014;89(2):75-84. http://bit.ly/3UflWbc

SFP: Zwerling B, Edelman A, Jackson A, et al. Society of Family Planning Clinical Recommendation: Medication abortion between 14 0/7 and 27 6/7 weeks of gestation: Jointly developed with the Society for Maternal-Fetal Medicine. Am J Obstet Gynecol. 2023 Oct 9:S0002-9378(23)00726-3. https://bit.ly/4iMELy4

Silver RM, Branch DW. Placenta Accreta Spectrum. N Engl J Med. 2018 Apr 19;378(16):1529-1536. https://bit.ly/4cbXYqj

Sium AF, Prager S, Wolderufael M, et al. Foley catheter for cervical preparation prior to second trimester dilation and evacuation: A supply-based alternative for surgical abortion: A case series. Contracept X. 2022 Oct 13;4:100085. http://bit.ly/40MoKyP

Socha MW, Flis W, Wartęga M, et al. A Review of the Mechanism of Action and Clinical Applications of Osmotic Dilators for Cervical Ripening in the Induction of Labor and in Gynecology Procedures. Med Sci Monit. 2023 Jun 27;29:e940127. https://bit.ly/3Y3Ua4u

Stillman M, Owolabi O, Fatusi AO, et al. Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria. BMJ Open. 2020 May 5;10(5):e034670. https://bit.ly/2TK4AVX

Turner KL, Hyman AG, Gabriel MC. Clarifying Values and Transforming Attitudes to Improve Access to Second Trimester Abortion, Reproductive Health Matters, 2008;16:sup31, 108-116. http://bit.ly/3nhptti

Upadhyay UD, Desai S, Zlidar V, et al. Incidence of emergency department visits and complications after abortion. Obstet Gynecol. 2015 Jan;125(1):175-183. https://bit.ly/3u3e80C

Whitehouse K, Fontanilla T, Kim L, et al. Use of medications to decrease bleeding during surgical abortion: a survey of abortion providers’ practices in the United States. Contraception. 2018 Jun;97(6):500-503. https://bit.ly/4iGEWuG

World Health Organization. Safe Abortion: Technical and Policy Guidance for Health Systems, 2nd ed. Geneva: 2012. https://bit.ly/3M0l6wK

World Health Organization Abortion Care Guidelines. 2022. https://bit.ly/3sOpXas